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Introduction
Highly effective combination anti-retroviral therapy (c-
ART) has been applied in Bulgaria since 1999. The aim of
the present study was to compare retrospectively the long-
term immunological effect of c-ART in treatment-naïve
and pre-treated HIV-1+ patients.
Patients and methods
The study included HIV-1+ patients (n=56) that have
started c-ART between March 1999 and December 2001,
have been on continuous treatment, with good adherence,
death being the only reason for ART stop. Of them, 27
had a history of irregular pre-treatment with AZT or
AZT/LMV for an average of 4.6 yrs (Group A), and 29
were ART-naïve (Group B). CD4 absolute counts (AC)
were determined by single-platform flow cytometry (BD
Biosciences). Viral load (VL) was measured by RT-PCR
(Roche). Comparisons were performed by unpaired t-test
(SPSS 17.0).
Results
The demographic characteristics of groups A and B did
not differ significantly: mean age (yrs): 34 vs. 35; male to
female ratio: 9 vs. 7, respectively. Baseline CD4 AC (cells/
ml) and VL (log HIV RNA copies/ml) were comparable:
mean 124 vs. 119, and 5.1 vs. 4.6, respectively, (p>0.05
for both comparisons). In the long term, suppression of
viral replication was observed in both groups: mean VL
a t5y r s3 . 7v s .3 . 1f o rg r o u p sAa n dB ,r e s p e c t i v e l y ,
(p>0.05). However, treatment-naïve patients (group B)
had a better immune recovery than group A, and the dif-
ference became significant in the long term: mean CD4
AC 177 vs. 252 after 6 months of c-ART, (p>0.05), 391
vs. 240 at 2 yrs (p
Conclusion
Similarly to other studies, (SHM Monitoring report,
2009), a more complete and lasting long-term immunolo-
gic response to c-ART was observed in treatment – naïve
patients. According to us, a previous sub-optimal and
irregularly applied ART regimen, may promote the selec-
tion of gradually outgrowing drug-resistant viral strains,
compromising therapeutic efficacy in the long run.
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